The rules of immunity: What decides T cell fate?
T cells are positioned at the frontline of the body's immune system to fight infection, cancer, and autoimmune disease. While ...
Hosted on MSN2d
Medigene and EpimAb to develop T cell engagers for solid tumours
Medigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell ...
Science News17h
A child who got CAR-T cancer therapy is still disease-free 18 years later
As part of a clinical trial, the girl received CAR-T cell therapy, a treatment that requires removing some of a patient’s immune cells and programming them to target and kill cancer cells before ...
The American Journal of Managed Care5d
Allogeneic vs Autologous CAR T-Cell Therapy Explained
Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...
Healio13d
FDA accepts IND for allogenic CAR T-cell therapy that could bypass lymphodepletion
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
The Scientist12h
A Rare White Blood Cell Boosts Cancer-Fighting Immune Cells
Basophils trigger a cytokine cascade that improves antitumor immunity in mice, offering potential targets for cancer ...
Rolling Out6d
A rare cancer, modified cells, and the future they promised
A couple facing a terminal multiple myeloma diagnosis finds renewed hope through innovative immunotherapy, transforming blood ...
manilatimes2h
IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
Simultaneous expansion and activation of both major γδ T cell subsets (Vδ1+ and Vδ2+) leverages both the rapid antigen ...
Wānaka blood cancer patient, 36, to get cutting-edge CAR T-cell therapy in China - why experts want the therapy here
Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...
unige.ch3d
Professor Paula Nunes-Hasler awarded INNOGAP and INNOSSUISE grants for groundbreaking T Cell Research
Professor Paula Nunes-Hasler, Assistant Professor at the UNIGE Faculty of Medicine, has been awarded INNOGAP and INNOSUISSE grants to advance research on ImmuneCell Booster compounds, a promising new ...